According to Goldstein Research, global neurological biomarkers market is expected grow at a CAGR of 7.4% over the forecast period 2017-2025. Even after immense technological development, neurology remains most complicated & unsolved segment. Therefore, neurological biomarker market is anticipated to grow at high CAGR over the forecast period as it leads to multiple application such as drug discovery and development, disease diagnostic and others.Based on application segmentation, drug discovery and development segment accounted for 29.0% market share of total global neurological biomarkers market. Further the expansion of biomarker validation and testing market has opened growth opportunities in the accurate application of neurological biomarkers. Furthermore, global imaging biomarker market has led to development of ‘precision medicine’ where,as per individual patient the tailored treatment is available. Therefore growth of imaging biomarker coupled with rising usage of metabolomics, genomics, proteomics, bioinformatics and advanced technologies and investments is by large driving the growth of the market.
Browse Full Report:
On the basis of our in-depth analysis, Global Neurological Biomarkers Market can be segmented as follows:
- Disease Related Biomarker
- Diagnostic Biomarker
- Prognostic Biomarker
- Drug Related Biomarker
- Imaging Biomarker
- Molecular Biomarker
- Surrogate Biomarker
By Product Type
- Gene products
- Drug Discovery and Development
- Disease Diagnosis
- Genetic Studies
- Molecular Diagnostics
- Others (Forensic Application, etc.)
- Pharmaceutical Companies
- Research Labs and Institutes
- North America Neurological Biomarkers Market Analysis, 2017-2025
- Europe Neurological Biomarkers Market Analysis, 2017-2025
- Middle East And Africa Neurological Biomarkers Market Analysis, 2017-2025
- Latin America Neurological Biomarkers Market Analysis, 2017-2025
- Asia Pacific Neurological Biomarkers Market Analysis, 2017-2025
“Global Neurological Biomarkers Market Outlook 2025” includes comprehensive overview of the global neurological biomarkers market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by type, product type, application, end user and geography.
The Global Neurological Biomarkers Market Report highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities andinvestments. The comprehensive analysis of neurological biomarkers market report is drafted as per the clients to help them in assessing their business strategies in the competitive environment.
Further, Global Neurological Biomarkers Market Report encompasses the key factors driving the growth of the market, opportunities in the market and the factors posing threats & challenges to the market. The neurological biomarkersMarket Outlook also comprises the market dynamics, risk analysis, SWOT analysis, USP analysis, BPS Analysis & market attractiveness. Report further also includes the expert analysis and remarks showcasing the complete overview of the market based on intensive analysis of political, economic, social, technological, environmental & legal factors of each region in the market.
The bioinformatics market is expected to grow at a CAGR of 20.5% over the forecast period 2016-2024 to reach a market size of USD 17.5billion by 2024. Major driving factor for bioinformatics market is the application and development of data mining techniques to solve biological problems as analyzing large biological data sets requires making sense of the data by inferring structure or generalizations from the data.
The Genomics Market is About to Change Healthcare sector with significant emergence Digital Genome Market as digitization of life is compelling companies in numerous industries to imagine how biotech could help enhance their top and bottom lines, whether by curbing product development timelines or generating new products that were never before imaginable. The genomics market size is set to reach USD 24.5 billion by 2025, at a CAGR of 11.2% over the forecast years. Where Gene Editing Market size is expected to reach USD 8.56 billion by 2025, growing at a compounded annual growth rate of 13.2% during the forecast period 2017-2025.
Oncology Biosimilars Market
The global oncology biosimilars market is expected to grow at 25.0% CAGR over the forecast period 2017-2025. The factors such as growth in a number of cancer patients, a rising number of hospitals, and a large number of oncology biosimilars in the pipeline are driving the growth of the Oncology Biosimilars Market. The expansion of the market is positively impacted by expanding the R&D of biomarkers such as in Cancer treatment.